Phathom Pharmaceuticals Inc. (PHAT)
Market Open
12 Jun, 13:53
NASDAQ (NGS) NASDAQ (NGS) Primary $
10. 40
+0.13
+1.2405%
$
786.39M Market Cap
- P/E Ratio
- Div Yield
37,261 Volume
-4.59 Eps
$ 10.27
Previous Close Want to track PHAT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Phathom Pharmaceuticals Inc. (PHAT) Statistics
Valuation metrics
Market Cap 786.39M
Enterprise value 629.65M
Trailing P/E (ttm) -5.28
Forward P/E -
PEG ratio -0.05
Price/Sales (ttm) 3.94
Price/Book (mrq) -2.47
Enterprise Value/Revenue 3.07
Enterprise Value/EBITDA -6.56
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.55M
Average volume (90 days) 1.24M
Price summary
52-Week low 7.61
52-Week high 18.31
Beta -
50-Day moving average 11.67
200-Day moving average 13
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.77%
Operating margin -0.47%
Operational effectiveness
Return on assets -0.52%
Return on equity 0.39%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 2.5
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.92
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.2
Total debt (mrq) -
Total Debt/Equity (mrq) -0.01
Current ratio (mrq) 2.21%
Book value per share (mrq) -4.11
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
